Regeneron isn’t the only Big Pharma to spot potential in Hansoh’s obesity pipeline. Merck & Co. ended last year paying $112 ...

Regeneron Pharmaceuticals, Inc. (REGN) on Monday said that it has entered into a strategic in-licensing agreement with ...

A new study shows obesity may lead to anxiety-like behaviour through changes in brain function and gut microbiota.

Regeneron’s shares have declined nearly 17% following the failure of the company’s Dupixent follow-up itepekimab.

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

"So the risk factors or causes of obesity are inclusive of an unhealthy diet, a sedentary lifestyle, genetics plays a role, ...

Obesity can lead to a host of other medical problems, such as diabetes, infertility, hypertension, heart disease, even ...

That overweight person you’re judging might not be able to control the amount they eat. For ten years, Joshua Bell was part ...

With rates of obesity and anxiety both on the rise-especially among younger Americans-new research suggests that the two ...

Ms. McKay is a war and humanitarian-focused international correspondent and author of 'Only Cry for the Living: Memos from ...

A new study suggests that urban environments may influence how impulsivity disorders like ADHD contribute to the obesity ...

Metabolic-associated fatty liver disease is prevalent in children and adolescents with severe obesity, with higher insulin ...